Long-Acting Reversible Contraception

Completed · Phase 4

Conditions studied: Contraception

In brief

In the proposed study, women aged 18-29 seeking oral or injectable contraception will be offered an opportunity to try LARC instead; the FDA-approved options include two types of intrauterine products and one type of subdermal contraceptive implant. Over a 24 month period, the experiences of LARC users will be compared to the experiences of those opting for their initial short-acting method.

Key facts

Study ID

NCT01299116

Run by

FHI 360

People needed

916

Starts

2011-12-01

Expected to finish

2016-12-01

Last updated by the study team

2018-02-28

Who can join

Age: 18 and older, up to 29. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• 18 to 29 years of age;
• sexually active;
• seeking oral or injectable contraception;
• working cell phone;
• working email account;
• willingness to be contacted by the clinic staff or study coordinators; and,
• willingness to complete questionnaires.

You may not qualify if…

• currently pregnant;
• previous use of a long-acting reversible contraceptive (LARC) method; and,
• medical contraindications for oral contraceptives and injectables.

Where it is running

• Planned Parenthood Central North Carolina — Chapel Hill, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.